Serum osteocalcin as a novel biomarker for differentiating growth hormone deficiency from idiopathic short stature

Serum OC shows high diagnostic value for distinguishing GHD from ISS, demonstrating significant clinical utility.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-03-11
DOI
https://doi.org/10.3389/fendo.2026.1745971
Primary Topic
Growth Hormone and Insulin-like Growth Factors
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serum osteocalcin as a novel biomarker for differentiating growth hormone deficiency from idiopathic short stature

Hongye Wang, Huanzhen Zhou, H. J. Yang, Yu Wang et al.
Frontiers in Endocrinology
Growth Hormone and Insulin-like Growth Factors
article

Serum osteocalcin as a novel biomarker for differentiating growth hormone deficiency from idiopathic short stature

Hongye Wang, Huanzhen Zhou, H. J. Yang, Yu Wang, Yang Chen, Hongcun Zheng, Aiping Wang, Jianying Ma
article en

Abstract

Serum OC shows high diagnostic value for distinguishing GHD from ISS, demonstrating significant clinical utility.

Frontiers in EndocrinologyVol. 17
Kunming Medical University (CN), First Affiliated Hospital of Kunming Medical University (CN), Dali University (CN)
Kunming Medical University, Division of Graduate Education
Openalex Percentile: Top 28%
Growth Hormone and Insulin-like Growth Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.